drugset / Trial / NCT04761341

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment

NCT04761341 ↗

Phase 4 Completed 28 enrolled Insel Gruppe AG, University Hospital Bern
Non-randomizedParallel-groupOpen-labelPrevention

Summary

To investigate the effects of lutein supplementation on macular pigment density using FLIO and MPOD measurements in patients with age-related macular degeneration and healthy subjects over a course of 6 months.

Timeline

Start
2018-06-01
Primary completion
2019-10-22
Completion
2019-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject NUTROF TOTAL Unknown — Oral